NALDEMEDINE

NALDEMEDINE was reported 1662 times

NALDEMEDINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 COMPUTED TOMOGRAPHIC GASTROGRAPHY 1 1.0000
1 APPLICATION SITE PURPURA 1 0.0625
2 HER2 POSITIVE GASTRIC CANCER 2 0.0625
3 LUNG ADENOCARCINOMA STAGE II 2 0.0588
4 INTERNAL CAROTID ARTERY DEFORMITY 1 0.0556
5 CHOROID NEOPLASM 1 0.0556
6 DUODENAL VASCULAR ECTASIA 1 0.0455
7 ENTEROCOLITIS FUNGAL 1 0.0333
8 COMBINED PULMONARY FIBROSIS AND EMPHYSEMA 2 0.0282
9 IMMUNE-MEDIATED OESOPHAGITIS 2 0.0278
10 METASTATIC BRONCHIAL CARCINOMA 5 0.0260
11 RENAL ISCHAEMIA 14 0.0256
12 HAEMORRHAGIC TUMOUR NECROSIS 1 0.0213
13 INTENSIVE CARE UNIT DELIRIUM 1 0.0208
14 PARALYSIS RECURRENT LARYNGEAL NERVE 3 0.0205
15 AMOEBIC DYSENTERY 2 0.0202
16 NEUROFIBROSARCOMA 2 0.0194
17 ABSCESS OF EYELID 1 0.0179
18 CSF GLUCOSE DECREASED 2 0.0172
19 FEMORAL ARTERY EMBOLISM 1 0.0169
20 IMMUNE-MEDIATED GASTRITIS 3 0.0156
21 MEDICAL DEVICE SITE ABSCESS 1 0.0145
22 IMMUNE-MEDIATED CHOLANGITIS 5 0.0139
23 INTESTINAL METASTASIS 5 0.0138
24 INTESTINAL FISTULA INFECTION 1 0.0137
25 ANTICHOLINERGIC EFFECT 1 0.0133
26 METASTASES TO STOMACH 5 0.0128
27 DIFFUSE LARGE B-CELL LYMPHOMA STAGE III 1 0.0127
28 GINGIVAL CANCER 1 0.0104
29 IMMUNE-MEDIATED HEPATIC DISORDER 20 0.0102
30 BLADDER TAMPONADE 3 0.0099
31 TUMOUR PERFORATION 3 0.0094
32 CYTOMEGALOVIRUS GASTROENTERITIS 2 0.0093
33 BRONCHOSTENOSIS 5 0.0091
34 METASTASES TO PANCREAS 4 0.0090
35 LARYNGOPHARYNGITIS 1 0.0090
36 FOREIGN BODY INGESTION 1 0.0089
37 KL-6 INCREASED 2 0.0088
38 THROMBOPHLEBITIS MIGRANS 3 0.0088
39 IMMUNE-MEDIATED PNEUMONITIS 2 0.0085
40 CEREBROSPINAL FLUID RETENTION 1 0.0085
41 GENERAL PHYSICAL CONDITION 1 0.0085
42 FAECALITH 1 0.0083
43 BRACHIOCEPHALIC VEIN THROMBOSIS 1 0.0081
44 CANDIDA SEPSIS 7 0.0078
45 COLORECTAL CANCER RECURRENT 1 0.0078
46 BLADDER PERFORATION 3 0.0078
47 PACHYMENINGITIS 2 0.0077
48 IMMUNE-MEDIATED RENAL DISORDER 3 0.0072
49 BULBAR PALSY 2 0.0072
50 CONTRAINDICATED DRUG PRESCRIBED 2 0.0071
51 IMMUNE-MEDIATED LUNG DISEASE 12 0.0066
52 COAGULATION FACTOR DEFICIENCY 1 0.0062
53 TRIPLE NEGATIVE BREAST CANCER 4 0.0059
54 METASTASES TO RETROPERITONEUM 1 0.0059
55 INTERLEUKIN-2 RECEPTOR INCREASED 1 0.0058
56 FULMINANT TYPE 1 DIABETES MELLITUS 6 0.0058
57 ADRENOCORTICOTROPIC HORMONE DEFICIENCY 5 0.0057
58 IMMUNE-MEDIATED UVEITIS 1 0.0055
59 ANAL FISSURE HAEMORRHAGE 1 0.0054
60 IMMUNE-MEDIATED ENTEROCOLITIS 20 0.0054
61 LARYNGEAL INFLAMMATION 1 0.0053
62 HAEMATOPOIETIC NEOPLASM 1 0.0053
63 THROMBOTIC CEREBRAL INFARCTION 2 0.0053
64 IMMUNE-MEDIATED PANCREATITIS 2 0.0052
65 CYTOMEGALOVIRUS ENTEROCOLITIS 4 0.0052
66 MESENTERIC VEIN THROMBOSIS 5 0.0050
67 HEART VALVE CALCIFICATION 1 0.0050
68 IMMUNE-MEDIATED DERMATITIS 5 0.0050
69 BRONCHIAL FISTULA 1 0.0050
70 CHOLANGITIS SCLEROSING 10 0.0049
71 ADRENOMEGALY 1 0.0048
72 LYMPHANGIOSIS CARCINOMATOSA 5 0.0048
73 DEFAECATION DISORDER 3 0.0045
74 HISTAMINE INTOLERANCE 1 0.0044
75 ALBUMIN GLOBULIN RATIO DECREASED 1 0.0043
76 CRANIAL NERVE PARALYSIS 2 0.0042
77 CARDIAC FAILURE HIGH OUTPUT 1 0.0041
78 INFECTIVE SPONDYLITIS 1 0.0041
79 FUNGAL PHARYNGITIS 1 0.0040
80 IMMUNE-MEDIATED HYPERTHYROIDISM 1 0.0039
81 HYPONATRAEMIC SEIZURE 1 0.0039
82 CANCER PAIN 10 0.0039
83 PULMONARY ARTERY THROMBOSIS 3 0.0039
84 IMMUNE-MEDIATED ENCEPHALITIS 2 0.0038
85 INTERLEUKIN LEVEL INCREASED 2 0.0036
86 PERIPHERAL MOTOR NEUROPATHY 5 0.0036
87 HUMAN HERPESVIRUS 6 ENCEPHALITIS 1 0.0035
88 ABDOMINAL MASS 9 0.0034
89 MESENTERIC PANNICULITIS 1 0.0033
90 SMALL CELL LUNG CANCER 5 0.0033
91 PALATAL DISORDER 2 0.0033
92 BLADDER INJURY 1 0.0031
93 EXTRAOCULAR MUSCLE DISORDER 1 0.0031
94 ENTEROCOCCUS TEST POSITIVE 2 0.0031
95 GASTRIC VARICES HAEMORRHAGE 1 0.0030
96 CENTRAL HYPOTHYROIDISM 1 0.0030
97 CATHETER SITE BRUISE 1 0.0030
98 DRUG MONITORING PROCEDURE INCORRECTLY PERFORMED 2 0.0030
99 MALIGNANT PLEURAL EFFUSION 5 0.0030
100 ALCOHOLIC LIVER DISEASE 1 0.0029
101 IMMUNE-MEDIATED HEPATITIS 6 0.0029
102 NON-SMALL CELL LUNG CANCER 14 0.0029
103 COMPUTERISED TOMOGRAM THORAX ABNORMAL 2 0.0029
104 ANASTOMOTIC COMPLICATION 1 0.0029
105 CHOLANGITIS 18 0.0029
106 LARGE INTESTINAL ULCER HAEMORRHAGE 1 0.0029
107 CLEAR CELL RENAL CELL CARCINOMA 2 0.0029
108 LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION 1 0.0029
109 FAECAL OCCULT BLOOD POSITIVE 1 0.0028
110 LABELLED DRUG-DRUG INTERACTION ISSUE 4 0.0028
111 MALIGNANT NEOPLASM OF UNKNOWN PRIMARY SITE 1 0.0027
112 CORNEAL REFLEX DECREASED 1 0.0027
113 HEPATIC INFARCTION 1 0.0027
114 IMMUNE-MEDIATED ARTHRITIS 1 0.0026
115 BONE TUBERCULOSIS 1 0.0026
116 INTRACRANIAL TUMOUR HAEMORRHAGE 1 0.0026
117 IMMUNE-MEDIATED ADRENAL INSUFFICIENCY 2 0.0025
118 BILE DUCT STENOSIS 3 0.0025
119 ECTHYMA 1 0.0025
120 HAEMOBILIA 1 0.0024
121 INFREQUENT BOWEL MOVEMENTS 6 0.0024
122 SEROUS RETINAL DETACHMENT 2 0.0024
123 INFLUENZA A VIRUS TEST POSITIVE 1 0.0023
124 ELECTROCARDIOGRAM ST-T SEGMENT ABNORMAL 1 0.0022
125 GASTROINTESTINAL HYPOMOTILITY 5 0.0022
126 ALLERGY TO PLANTS 1 0.0022
127 CIRRHOSIS ALCOHOLIC 1 0.0022
128 IMMUNE-MEDIATED NEPHRITIS 1 0.0021
129 THERAPEUTIC RESPONSE INCREASED 2 0.0021
130 ECZEMA ASTEATOTIC 1 0.0021
131 MENINGITIS BACTERIAL 3 0.0021
132 FAECAL VOLUME DECREASED 1 0.0021
133 PNEUMONIA CYTOMEGALOVIRAL 4 0.0021
134 BLOOD CORTICOTROPHIN DECREASED 1 0.0020
135 GALLBLADDER CANCER 3 0.0020
136 AUTOIMMUNE PANCREATITIS 1 0.0020
137 IMMUNE-MEDIATED ADVERSE REACTION 3 0.0020
138 CORONAVIRUS TEST POSITIVE 2 0.0019
139 DIVERTICULAR PERFORATION 4 0.0019
140 GASTROINTESTINAL PERFORATION 8 0.0019
141 ENTEROCOLITIS 11 0.0019
142 TUMOUR NECROSIS 2 0.0019
143 BONE CANCER METASTATIC 1 0.0019
144 GASTRIC PERFORATION 5 0.0018
145 CHRONIC MYELOID LEUKAEMIA RECURRENT 1 0.0018
146 ADRENAL HAEMORRHAGE 1 0.0018
147 DIVERTICULUM INTESTINAL HAEMORRHAGIC 4 0.0018
148 IMMUNE-MEDIATED HYPOTHYROIDISM 2 0.0018
149 MECHANICAL ILEUS 1 0.0018
150 TUMOUR HAEMORRHAGE 5 0.0018
151 DUODENAL ULCER HAEMORRHAGE 5 0.0017
152 RADIATION SKIN INJURY 2 0.0017
153 CELLULITIS ORBITAL 1 0.0017
154 PULMONARY TOXICITY 12 0.0017
155 LYMPHATIC DISORDER 1 0.0017
156 INTERSTITIAL LUNG DISEASE 81 0.0017
157 MEAN PLATELET VOLUME INCREASED 1 0.0017
158 CYTOKINE RELEASE SYNDROME 33 0.0016
159 HYPERGAMMAGLOBULINAEMIA BENIGN MONOCLONAL 1 0.0016
160 CEREBRAL ASPERGILLOSIS 1 0.0016
161 INAPPROPRIATE PRESCRIBING 1 0.0016
162 BLOOD BILIRUBIN DECREASED 1 0.0016
163 MEDICAL DEVICE SITE INFECTION 1 0.0016
164 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 2 0.0016
165 HEPATOBILIARY DISEASE 1 0.0016
166 HEPATIC INFECTION 2 0.0016
167 PHYSICAL DECONDITIONING 4 0.0016
168 GASTROINTESTINAL MUCOSAL DISORDER 1 0.0015
169 PNEUMONIA BACTERIAL 14 0.0015
170 ANISOCYTOSIS 1 0.0015
171 ILEAL PERFORATION 1 0.0015
172 EMBOLIC CEREBRAL INFARCTION 1 0.0015
173 METASTASES TO LYMPH NODES 10 0.0015
174 HEAD AND NECK CANCER 1 0.0015
175 HEPATIC FUNCTION ABNORMAL 54 0.0014
176 SUBILEUS 3 0.0014
177 CERVICAL RADICULOPATHY 1 0.0014
178 DYSLALIA 1 0.0014
179 EOSINOPHILIC MYOCARDITIS 1 0.0014
180 AUTONOMIC NERVOUS SYSTEM IMBALANCE 4 0.0014
181 CLONIC CONVULSION 1 0.0014
182 HEMIANOPIA HOMONYMOUS 1 0.0014
183 TUMOUR LYSIS SYNDROME 12 0.0014
184 DIFFERENTIATION SYNDROME 1 0.0014
185 HEPATITIS FULMINANT 4 0.0013
186 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 3 0.0013
187 GASTROINTESTINAL WALL THICKENING 2 0.0013
188 GINGIVAL ABSCESS 1 0.0013
189 CHOLANGITIS ACUTE 1 0.0013
190 SECONDARY ADRENOCORTICAL INSUFFICIENCY 2 0.0013
191 INFECTIOUS PLEURAL EFFUSION 2 0.0013
192 PNEUMONIA PSEUDOMONAL 2 0.0013
193 CREATINE KINASE INCREASED 1 0.0013
194 INADEQUATE ANALGESIA 11 0.0013
195 LYMPHOCYTE STIMULATION TEST POSITIVE 1 0.0012
196 HERPES ZOSTER DISSEMINATED 1 0.0012
197 DELIRIUM 43 0.0012
198 ATYPICAL HAEMOLYTIC URAEMIC SYNDROME 1 0.0012
199 GIANT CELL ARTERITIS 1 0.0012
200 TROPONIN I INCREASED 2 0.0012
201 METASTASES TO PERITONEUM 3 0.0012
202 CEREBRAL VENOUS SINUS THROMBOSIS 1 0.0012
203 ENTERITIS INFECTIOUS 2 0.0012
204 GASTROINTESTINAL NEOPLASM 1 0.0012
205 GASTROINTESTINAL FISTULA 1 0.0011
206 LUNG OPACITY 3 0.0011
207 ILEUS PARALYTIC 5 0.0011
208 BLOOD MAGNESIUM INCREASED 1 0.0011
209 PNEUMOMEDIASTINUM 2 0.0011
210 IMMUNE THROMBOCYTOPENIA 5 0.0011
211 OTOTOXICITY 2 0.0011
212 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0011
213 SMALL INTESTINAL PERFORATION 2 0.0011
214 INJECTION SITE ULCER 1 0.0011
215 INJECTION SITE SCAB 1 0.0010
216 CERVIX CARCINOMA 4 0.0010
217 ORAL INFECTION 4 0.0010
218 DUST ALLERGY 1 0.0010
219 HYPOGEUSIA 2 0.0010
220 DACTYLITIS 1 0.0010
221 OCCULT BLOOD POSITIVE 2 0.0010
222 ANORECTAL DISORDER 2 0.0010
223 LUNG ADENOCARCINOMA 3 0.0010
224 HYPOPHYSITIS 2 0.0010
225 VENOUS THROMBOSIS LIMB 2 0.0010
226 MALIGNANT NEOPLASM PROGRESSION 98 0.0010
227 URINARY BLADDER HAEMORRHAGE 2 0.0009
228 COMPRESSION FRACTURE 5 0.0009
229 AMYOTROPHIC LATERAL SCLEROSIS 2 0.0009
230 LIVER ABSCESS 3 0.0009
231 PERIODONTITIS 2 0.0009
232 DISSEMINATED INTRAVASCULAR COAGULATION 13 0.0009
233 GASTROINTESTINAL TRACT IRRITATION 1 0.0009
234 PNEUMOCYSTIS JIROVECII PNEUMONIA 9 0.0009
235 PSEUDOMEMBRANOUS COLITIS 2 0.0009
236 CHOLECYSTITIS ACUTE 5 0.0009
237 CORTISOL DECREASED 1 0.0009
238 ARTERIAL HAEMORRHAGE 1 0.0009
239 INTERNATIONAL NORMALISED RATIO ABNORMAL 3 0.0009
240 DIFFUSE ALVEOLAR DAMAGE 1 0.0009
241 BREAKTHROUGH PAIN 2 0.0009
242 ERYTHEMA MULTIFORME 8 0.0009
243 JC POLYOMAVIRUS TEST POSITIVE 1 0.0009
244 HYPERTENSIVE EMERGENCY 1 0.0008
245 SPINAL COMPRESSION FRACTURE 7 0.0008
246 BILE DUCT CANCER 1 0.0008
247 HAEMATOMA MUSCLE 1 0.0008
248 CLOSTRIDIUM COLITIS 1 0.0008
249 ADRENAL INSUFFICIENCY 10 0.0008
250 BLOOD IMMUNOGLOBULIN G INCREASED 1 0.0008
251 CEREBRAL ARTERY EMBOLISM 1 0.0008
252 ILEUS 10 0.0008
253 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 6 0.0008
254 ADENOCARCINOMA PANCREAS 1 0.0008
255 CARDIAC VENTRICULAR THROMBOSIS 1 0.0008
256 SINUS TACHYCARDIA 11 0.0008
257 HYPOALBUMINAEMIA 6 0.0008
258 FAECES HARD 3 0.0008
259 NEUTROPHIL COUNT DECREASED 31 0.0008
260 CHOLECYSTITIS 9 0.0008
261 HYPOVITAMINOSIS 1 0.0008
262 FEBRILE NEUTROPENIA 50 0.0008
263 LYMPHOCYTE PERCENTAGE DECREASED 1 0.0007
264 BLOOD SODIUM INCREASED 2 0.0007
265 METASTASES TO LIVER 13 0.0007
266 LARGE INTESTINAL ULCER 2 0.0007
267 IMMUNE-MEDIATED MYOSITIS 2 0.0007
268 MAST CELL ACTIVATION SYNDROME 1 0.0007
269 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 1 0.0007
270 ATYPICAL MYCOBACTERIAL INFECTION 1 0.0007
271 OESOPHAGEAL STENOSIS 2 0.0007
272 PNEUMATOSIS INTESTINALIS 2 0.0007
273 METASTASES TO CENTRAL NERVOUS SYSTEM 9 0.0007
274 INVESTIGATION ABNORMAL 1 0.0007
275 DYSPNOEA AT REST 2 0.0007
276 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 4 0.0007
277 METASTASES TO BONE 11 0.0007
278 THYROIDITIS 2 0.0007
279 TOXIC EPIDERMAL NECROLYSIS 10 0.0007
280 MARASMUS 1 0.0007
281 DYSCHEZIA 2 0.0007
282 LUMBAR VERTEBRAL FRACTURE 3 0.0007
283 CALCULUS URINARY 1 0.0006
284 MEAN CELL VOLUME DECREASED 1 0.0006
285 ALTERED STATE OF CONSCIOUSNESS 14 0.0006
286 HYPERTROPHIC CARDIOMYOPATHY 1 0.0006
287 FOREIGN BODY IN THROAT 2 0.0006
288 DRUG EFFECT INCREASED 2 0.0006
289 GUILLAIN-BARRE SYNDROME 3 0.0006
290 IMMUNE-MEDIATED MYOCARDITIS 1 0.0006
291 LUNG NEOPLASM MALIGNANT 25 0.0006
292 INABILITY TO AFFORD MEDICATION 6 0.0006
293 PROTEIN URINE PRESENT 3 0.0006
294 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 1 0.0006
295 METASTASES TO SPINE 2 0.0006
296 DRUG TOLERANCE 3 0.0006
297 CEREBELLAR INFARCTION 1 0.0006
298 GAZE PALSY 1 0.0006
299 APLASIA PURE RED CELL 2 0.0006
300 ACUTE SINUSITIS 1 0.0006
301 DEPRESSION SUICIDAL 2 0.0006
302 HYPOPITUITARISM 1 0.0006
303 EXTREMITY NECROSIS 1 0.0006
304 INFUSION SITE DISCHARGE 1 0.0006
305 SERUM FERRITIN INCREASED 3 0.0006
306 JAUNDICE CHOLESTATIC 2 0.0006
307 DEVICE ALARM ISSUE 1 0.0006
308 BLOOD PHOSPHORUS DECREASED 2 0.0005
309 MEAN CELL HAEMOGLOBIN DECREASED 1 0.0005
310 RECTAL DISCHARGE 2 0.0005
311 BLOOD THYROID STIMULATING HORMONE ABNORMAL 1 0.0005
312 CYTOMEGALOVIRUS INFECTION 9 0.0005
313 GASTRIC ULCER HAEMORRHAGE 3 0.0005
314 HYPERACUSIS 2 0.0005
315 HYPERTENSIVE HEART DISEASE 1 0.0005
316 MULTIPLE ORGAN DYSFUNCTION SYNDROME 15 0.0005
317 LIP DISORDER 1 0.0005
318 HYPERCOAGULATION 1 0.0005
319 LYMPHADENOPATHY MEDIASTINAL 1 0.0005
320 PNEUMONIA ASPIRATION 13 0.0005
321 HEPATIC MASS 1 0.0005
322 LIVER DISORDER 23 0.0005
323 PERIPHERAL SENSORY NEUROPATHY 3 0.0005
324 CONSTIPATION 111 0.0005
325 ALLERGIC REACTION TO EXCIPIENT 1 0.0005
326 CARDIAC DISCOMFORT 1 0.0005
327 MYASTHENIA GRAVIS 4 0.0005
328 STEVENS-JOHNSON SYNDROME 11 0.0005
329 INJECTION SITE NECROSIS 1 0.0005
330 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 1 0.0005
331 ESCHERICHIA INFECTION 4 0.0005
332 HYPERKALAEMIA 17 0.0005
333 HYPERBILIRUBINAEMIA 5 0.0005
334 BODY TEMPERATURE FLUCTUATION 1 0.0005
335 DRUG-INDUCED LIVER INJURY 15 0.0005
336 PULMONARY THROMBOSIS 5 0.0005
337 GASTROINTESTINAL ULCER 1 0.0005
338 PANCREATIC CARCINOMA 13 0.0004
339 FAECES PALE 1 0.0004
340 CYTOMEGALOVIRUS VIRAEMIA 2 0.0004
341 ADENOCARCINOMA 1 0.0004
342 INTESTINAL PERFORATION 5 0.0004
343 ELECTROCARDIOGRAM QT PROLONGED 16 0.0004
344 ANAL INCONTINENCE 4 0.0004
345 METASTASES TO MENINGES 1 0.0004
346 MYOCARDITIS 5 0.0004
347 BRAIN NEOPLASM 4 0.0004
348 BLOOD POTASSIUM INCREASED 7 0.0004
349 COVID-19 PNEUMONIA 5 0.0004
350 SKIN ABRASION 2 0.0004
351 INTRA-ABDOMINAL HAEMORRHAGE 1 0.0004
352 LACUNAR INFARCTION 1 0.0004
353 LONG QT SYNDROME 1 0.0004
354 GASTROINTESTINAL OBSTRUCTION 1 0.0004
355 ATELECTASIS 4 0.0004
356 CEREBRAL INFARCTION 10 0.0004
357 LOWER GASTROINTESTINAL HAEMORRHAGE 3 0.0004
358 DENTAL OPERATION 1 0.0004
359 NEOPLASM MALIGNANT 27 0.0004
360 BLOOD IMMUNOGLOBULIN G DECREASED 1 0.0004
361 COLON CANCER 6 0.0004
362 HYPERNATRAEMIA 2 0.0004
363 EXPOSURE VIA INGESTION 1 0.0004
364 ACUTE RESPIRATORY DISTRESS SYNDROME 7 0.0004
365 ABDOMINAL PAIN 92 0.0004
366 HEPATOCELLULAR CARCINOMA 3 0.0004
367 PLATELET COUNT DECREASED 42 0.0004
368 ABDOMINAL INFECTION 1 0.0004
369 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 4 0.0004
370 BLOOD CHLORIDE DECREASED 1 0.0004
371 PERITONITIS 8 0.0004
372 HERNIA REPAIR 1 0.0004
373 MALABSORPTION 2 0.0004
374 FOOD POISONING 2 0.0004
375 INVASIVE DUCTAL BREAST CARCINOMA 1 0.0004
376 PNEUMONITIS 10 0.0004
377 GAMMA-GLUTAMYLTRANSFERASE INCREASED 8 0.0004
378 ATYPICAL FEMUR FRACTURE 1 0.0004
379 IMMUNE THROMBOCYTOPENIC PURPURA 1 0.0004
380 HAEMATOLOGICAL MALIGNANCY 1 0.0004
381 PRESCRIBED UNDERDOSE 7 0.0004
382 NEOPLASM PROGRESSION 12 0.0003
383 STRESS CARDIOMYOPATHY 2 0.0003
384 LUMBAR SPINAL STENOSIS 1 0.0003
385 ANAEMIA 65 0.0003
386 DECREASED APPETITE 78 0.0003
387 TYPE 1 DIABETES MELLITUS 2 0.0003
388 HYPERCAPNIA 1 0.0003
389 SQUAMOUS CELL CARCINOMA OF SKIN 2 0.0003
390 HYPERGLYCAEMIA 12 0.0003
391 KERATITIS 1 0.0003
392 DUODENITIS 1 0.0003
393 BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0003
394 HYPERCALCAEMIA 4 0.0003
395 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 2 0.0003
396 PRE-EXISTING CONDITION IMPROVED 2 0.0003
397 BLOOD CREATININE DECREASED 1 0.0003
398 INTESTINAL OBSTRUCTION 12 0.0003
399 BREAST CANCER RECURRENT 1 0.0003
400 PROTEINURIA 6 0.0003
401 PNEUMOTHORAX 5 0.0003
402 SUPRAVENTRICULAR TACHYCARDIA 3 0.0003
403 HEPATITIS ACUTE 2 0.0003
404 BACTERIAL SEPSIS 1 0.0003
405 ASCITES 9 0.0003
406 INJECTION SITE INFECTION 1 0.0003
407 PANCYTOPENIA 17 0.0003
408 DEPRESSED LEVEL OF CONSCIOUSNESS 12 0.0003
409 CORONAVIRUS INFECTION 2 0.0003
410 CARDIAC FAILURE ACUTE 2 0.0003
411 HIGH DENSITY LIPOPROTEIN DECREASED 1 0.0003
412 MENINGITIS 2 0.0003
413 FREQUENT BOWEL MOVEMENTS 8 0.0003
414 POSTOPERATIVE WOUND INFECTION 2 0.0003
415 DIARRHOEA 191 0.0003
416 FEEDING DISORDER 6 0.0003
417 AUTOIMMUNE HAEMOLYTIC ANAEMIA 1 0.0003
418 CERVICAL VERTEBRAL FRACTURE 1 0.0003
419 FUNCTIONAL GASTROINTESTINAL DISORDER 1 0.0003
420 LYMPHOEDEMA 2 0.0003
421 ENCEPHALITIS 2 0.0003
422 HYPOPNOEA 1 0.0003
423 AUTOIMMUNE HEPATITIS 2 0.0003
424 CAROTID ARTERY STENOSIS 1 0.0003
425 LUNG DISORDER 14 0.0003
426 DEFAECATION URGENCY 2 0.0003
427 DRUG WITHDRAWAL SYNDROME 25 0.0003
428 BRONCHIOLITIS 1 0.0003
429 DEPRESSIVE SYMPTOM 1 0.0003
430 DRUG ERUPTION 5 0.0003
431 FIBRIN D DIMER INCREASED 1 0.0003
432 HAEMORRHAGIC DIATHESIS 1 0.0003
433 PLEURAL EFFUSION 17 0.0003
434 DISEASE PROGRESSION 33 0.0003
435 IMPAIRED QUALITY OF LIFE 4 0.0003
436 MYELOSUPPRESSION 10 0.0003
437 INTENTIONAL UNDERDOSE 2 0.0003
438 MOUTH HAEMORRHAGE 2 0.0003
439 URINARY RETENTION 9 0.0003
440 HYDRONEPHROSIS 2 0.0003
441 MYOCARDIAL ISCHAEMIA 3 0.0003
442 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
443 CLAVICLE FRACTURE 1 0.0003
444 DEVICE RELATED INFECTION 4 0.0003
445 LOW DENSITY LIPOPROTEIN INCREASED 2 0.0003
446 PRODUCT ADMINISTRATION INTERRUPTED 2 0.0003
447 BACTERAEMIA 3 0.0003
448 BLOOD ALBUMIN DECREASED 2 0.0003
449 HALLUCINATION, AUDITORY 4 0.0003
450 MYOCLONUS 3 0.0003
451 HAEMOPTYSIS 7 0.0003
452 ATRIAL FLUTTER 2 0.0003
453 RENAL IMPAIRMENT 21 0.0002
454 ARTERIOSPASM CORONARY 1 0.0002
455 UTERINE CANCER 2 0.0002
456 HYPONATRAEMIA 14 0.0002
457 CYSTITIS HAEMORRHAGIC 1 0.0002
458 C-REACTIVE PROTEIN INCREASED 9 0.0002
459 TASTE DISORDER 5 0.0002
460 BACK DISORDER 4 0.0002
461 SHOCK HAEMORRHAGIC 2 0.0002
462 HYPERURICAEMIA 1 0.0002
463 APPLICATION SITE EXFOLIATION 1 0.0002
464 EMBOLISM 2 0.0002
465 SECOND PRIMARY MALIGNANCY 2 0.0002
466 EOSINOPHIL COUNT INCREASED 2 0.0002
467 ABSCESS LIMB 1 0.0002
468 HEPATIC PAIN 1 0.0002
469 INTERVERTEBRAL DISC DISORDER 1 0.0002
470 HAEMATURIA 8 0.0002
471 PRODUCT CONTAINER ISSUE 2 0.0002
472 DEVICE OPERATIONAL ISSUE 1 0.0002
473 MUSCULOSKELETAL DISCOMFORT 4 0.0002
474 PYELONEPHRITIS 2 0.0002
475 FAECES DISCOLOURED 5 0.0002
476 MUCOSAL INFLAMMATION 6 0.0002
477 DIVERTICULUM INTESTINAL 1 0.0002
478 ORAL CANDIDIASIS 3 0.0002
479 PULMONARY CONGESTION 3 0.0002
480 HAEMORRHAGIC ANAEMIA 1 0.0002
481 MELAENA 5 0.0002
482 COLD SWEAT 4 0.0002
483 LYMPHOCYTE COUNT DECREASED 4 0.0002
484 ABDOMINAL ABSCESS 1 0.0002
485 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 2 0.0002
486 ASPARTATE AMINOTRANSFERASE INCREASED 12 0.0002
487 MYOSITIS 2 0.0002
488 WHITE BLOOD CELL COUNT DECREASED 24 0.0002
489 GASTROINTESTINAL CARCINOMA 2 0.0002
490 ACUTE HEPATIC FAILURE 3 0.0002
491 HYPOTHYROIDISM 7 0.0002
492 BUNDLE BRANCH BLOCK RIGHT 1 0.0002
493 ISCHAEMIA 1 0.0002
494 UROSEPSIS 2 0.0002
495 BLOOD PRESSURE DIASTOLIC INCREASED 1 0.0002
496 IRON DEFICIENCY ANAEMIA 2 0.0002
497 HYPOKALAEMIA 10 0.0002
498 LOCALISED OEDEMA 1 0.0002
499 AGRANULOCYTOSIS 4 0.0002
500 SEPSIS 24 0.0002
501 RENAL DISORDER 10 0.0002
502 STOMATITIS 13 0.0002
503 SEASONAL ALLERGY 3 0.0002
504 LEUKAEMIA 2 0.0002
505 HYPOCALCAEMIA 4 0.0002
506 GASTRIC ULCER 4 0.0002
507 CARDIAC TAMPONADE 1 0.0002
508 DRUG INTERACTION 33 0.0002
509 SEPTIC SHOCK 9 0.0002
510 PRESCRIBED OVERDOSE 4 0.0002
511 VITAMIN D DEFICIENCY 2 0.0002
512 HAEMORRHOIDAL HAEMORRHAGE 1 0.0002
513 INFLAMMATORY MARKER INCREASED 1 0.0002
514 BLADDER DISORDER 2 0.0002
515 ABDOMINAL TENDERNESS 1 0.0002
516 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 1 0.0002
517 ERYSIPELAS 1 0.0002
518 CORONARY ARTERY STENOSIS 1 0.0002
519 HYPOXIA 7 0.0002
520 EMPHYSEMA 2 0.0002
521 PRODUCT ADMINISTRATION ERROR 4 0.0002
522 KLEBSIELLA INFECTION 1 0.0002
523 ABDOMINAL PAIN LOWER 5 0.0002
524 GASTRIC CANCER 5 0.0002
525 DYSLIPIDAEMIA 1 0.0002
526 BONE MARROW FAILURE 4 0.0002
527 EYELID PTOSIS 2 0.0002
528 INSURANCE ISSUE 3 0.0002
529 AMMONIA INCREASED 1 0.0002
530 HYPOPHAGIA 5 0.0002
531 ALANINE AMINOTRANSFERASE INCREASED 12 0.0002
532 FEMORAL NECK FRACTURE 1 0.0002
533 CACHEXIA 1 0.0002
534 FOOD CRAVING 1 0.0002
535 ANAL FISTULA 1 0.0002
536 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
537 ANAL FISSURE 1 0.0002
538 GINGIVITIS 1 0.0002
539 PYREXIA 64 0.0002
540 DEAFNESS UNILATERAL 1 0.0002
541 PSYCHOMOTOR HYPERACTIVITY 3 0.0002
542 PLASMA CELL MYELOMA 7 0.0002
543 HEART RATE ABNORMAL 1 0.0002
544 BLOOD UREA INCREASED 3 0.0002
545 MALNUTRITION 2 0.0002
546 COLECTOMY 1 0.0002
547 GENERALISED ERYTHEMA 1 0.0002
548 GRANULOCYTOPENIA 1 0.0002
549 MICTURITION URGENCY 2 0.0002
550 CARDIAC FAILURE 14 0.0002
551 BLOOD URIC ACID INCREASED 1 0.0002
552 METASTASES TO LUNG 2 0.0002
553 POST PROCEDURAL HAEMORRHAGE 2 0.0002
554 HYPERTRIGLYCERIDAEMIA 1 0.0002
555 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
556 NEUROLEPTIC MALIGNANT SYNDROME 2 0.0002
557 DYSPHAGIA 16 0.0002
558 THIRST 3 0.0002
559 CEREBRAL HAEMORRHAGE 6 0.0002
560 NAUSEA 132 0.0002
561 ENDOPHTHALMITIS 1 0.0002
562 BLOOD PRESSURE INADEQUATELY CONTROLLED 1 0.0002
563 HEPATITIS B 1 0.0002
564 INJECTION SITE VESICLES 1 0.0002
565 RESTLESS LEGS SYNDROME 3 0.0002
566 HYPOGLYCAEMIA 8 0.0002
567 CYTOPENIA 2 0.0002
568 RESPIRATORY DEPRESSION 2 0.0002
569 ABDOMINAL DISTENSION 17 0.0002
570 MENISCUS INJURY 1 0.0002
571 SPINAL OPERATION 2 0.0002
572 OSTEONECROSIS OF JAW 4 0.0002
573 OXYGEN SATURATION DECREASED 9 0.0002
574 INTENTIONAL PRODUCT USE ISSUE 14 0.0002
575 HEPATIC CIRRHOSIS 3 0.0002
576 BLEPHAROSPASM 1 0.0002
577 DEHYDRATION 21 0.0002
578 MALAISE 69 0.0002
579 HEPATITIS 4 0.0002
580 ENTERITIS 1 0.0002
581 ACUTE RESPIRATORY FAILURE 3 0.0002
582 GENITAL HAEMORRHAGE 2 0.0002
583 INJECTION SITE INDURATION 2 0.0002
584 BONE PAIN 9 0.0002
585 ASPERGILLUS INFECTION 1 0.0002
586 DISORIENTATION 6 0.0002
587 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
588 APPETITE DISORDER 1 0.0002
589 SKIN DISORDER 5 0.0001
590 QUALITY OF LIFE DECREASED 2 0.0001
591 COLITIS ISCHAEMIC 1 0.0001
592 PALLOR 4 0.0001
593 IMPAIRED GASTRIC EMPTYING 2 0.0001
594 PERIPHERAL COLDNESS 2 0.0001
595 PROSTATIC SPECIFIC ANTIGEN INCREASED 2 0.0001
596 JOINT EFFUSION 1 0.0001
597 LARGE INTESTINE PERFORATION 1 0.0001
598 ORAL DISCOMFORT 2 0.0001
599 HALLUCINATION, VISUAL 3 0.0001
600 DUODENAL ULCER 1 0.0001
601 LYMPHOPENIA 2 0.0001
602 EATING DISORDER 3 0.0001
603 SUBDURAL HAEMATOMA 2 0.0001
604 CARDIOGENIC SHOCK 2 0.0001
605 HERPES ZOSTER 8 0.0001
606 GRAFT VERSUS HOST DISEASE 1 0.0001
607 DERMATITIS BULLOUS 1 0.0001
608 FAECES SOFT 1 0.0001
609 RESPIRATORY FAILURE 10 0.0001
610 GASTROENTERITIS 2 0.0001
611 MAJOR DEPRESSION 1 0.0001
612 ABDOMINAL PAIN UPPER 28 0.0001
613 DYSURIA 5 0.0001
614 INFUSION RELATED REACTION 9 0.0001
615 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
616 BLOOD PRESSURE DECREASED 9 0.0001
617 HYPOPHOSPHATAEMIA 1 0.0001
618 ARTHROPOD BITE 1 0.0001
619 RASH MACULO-PAPULAR 3 0.0001
620 LACRIMATION INCREASED 4 0.0001
621 CONTRAINDICATED PRODUCT ADMINISTERED 4 0.0001
622 AORTIC ANEURYSM 1 0.0001
623 ABDOMINAL DISCOMFORT 22 0.0001
624 LIPASE INCREASED 1 0.0001
625 SHOCK 3 0.0001
626 BRONCHOPULMONARY ASPERGILLOSIS 1 0.0001
627 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 1 0.0001
628 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 3 0.0001
629 VOMITING 60 0.0001
630 CYANOSIS 2 0.0001
631 DRUG SCREEN POSITIVE 1 0.0001
632 BLOOD LACTATE DEHYDROGENASE INCREASED 2 0.0001
633 FURUNCLE 1 0.0001
634 METABOLIC ACIDOSIS 4 0.0001
635 DIABETIC KETOACIDOSIS 3 0.0001
636 BLOOD DISORDER 1 0.0001
637 HYPERHIDROSIS 16 0.0001
638 PRESYNCOPE 3 0.0001
639 NEURALGIA 3 0.0001
640 DECUBITUS ULCER 1 0.0001
641 ASPHYXIA 1 0.0001
642 ENCEPHALOPATHY 3 0.0001
643 ABNORMAL FAECES 1 0.0001
644 HICCUPS 1 0.0001
645 BLOOD ALKALINE PHOSPHATASE INCREASED 3 0.0001
646 PNEUMONIA 39 0.0001
647 HEMIPLEGIA 1 0.0001
648 COAGULOPATHY 2 0.0001
649 POLLAKIURIA 5 0.0001
650 WITHDRAWAL SYNDROME 5 0.0001
651 UNEVALUABLE EVENT 9 0.0001
652 UPPER GASTROINTESTINAL HAEMORRHAGE 2 0.0001
653 INFUSION SITE ERYTHEMA 1 0.0001
654 FACE OEDEMA 2 0.0001
655 CANDIDA INFECTION 2 0.0001
656 HAEMATEMESIS 3 0.0001
657 OSTEOARTHRITIS 5 0.0001
658 FACIAL PARALYSIS 1 0.0001
659 BACK PAIN 27 0.0001
660 ANURIA 1 0.0001
661 NEUROPATHY PERIPHERAL 11 0.0001
662 CARDIAC MURMUR 1 0.0001
663 GASTRITIS 3 0.0001
664 LUNG INFILTRATION 1 0.0001
665 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
666 HEAD DISCOMFORT 2 0.0001
667 BLOOD BILIRUBIN INCREASED 3 0.0001
668 LEUKOCYTOSIS 2 0.0001
669 OSTEOMYELITIS 2 0.0001
670 NEUTROPENIA 15 0.0001
671 SOMNOLENCE 22 0.0001
672 RESPIRATORY ARREST 3 0.0001
673 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
674 DIVERTICULITIS 3 0.0001
675 DEEP VEIN THROMBOSIS 7 0.0001
676 BACTERIAL INFECTION 2 0.0001
677 HEPATIC ENCEPHALOPATHY 1 0.0001
678 APPENDICITIS 1 0.0001
679 FLANK PAIN 1 0.0001
680 OEDEMA PERIPHERAL 13 0.0001
681 DYSARTHRIA 4 0.0001
682 BLOOD SODIUM DECREASED 2 0.0001
683 FRACTURE 2 0.0001
684 COLITIS 4 0.0001
685 FOOT FRACTURE 2 0.0001
686 HAEMATOTOXICITY 1 0.0001
687 RED BLOOD CELL COUNT DECREASED 3 0.0001
688 ANGINA PECTORIS 3 0.0001
689 SEROTONIN SYNDROME 2 0.0001
690 HYPERCHOLESTEROLAEMIA 1 0.0001
691 DYSSTASIA 3 0.0001
692 AUTOIMMUNE DISORDER 1 0.0001
693 KNEE OPERATION 1 0.0001
694 HOSPICE CARE 1 0.0001
695 DISABILITY 2 0.0001
696 LIGAMENT SPRAIN 1 0.0001
697 HAEMATOCRIT DECREASED 2 0.0001
698 CATARACT 6 0.0001
699 LEUKOPENIA 5 0.0001
700 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 18 0.0001
701 HEPATIC FAILURE 3 0.0001
702 HYPERTENSION 21 0.0001
703 THERAPEUTIC RESPONSE DECREASED 6 0.0001
704 VERTIGO 6 0.0001
705 EPILEPSY 3 0.0001
706 BODY TEMPERATURE INCREASED 2 0.0001
707 ACUTE KIDNEY INJURY 15 0.0001
708 EAR DISCOMFORT 1 0.0001
709 LIMB DISCOMFORT 3 0.0001
710 CARDIO-RESPIRATORY ARREST 4 0.0001
711 CONDITION AGGRAVATED 29 0.0001
712 INCONTINENCE 1 0.0001
713 CYSTITIS 3 0.0001
714 BODY HEIGHT DECREASED 1 0.0001
715 MOVEMENT DISORDER 3 0.0001
716 BREAST CANCER METASTATIC 1 0.0001
717 HALLUCINATION 7 0.0001
718 RHINORRHOEA 6 0.0001
719 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
720 ASPIRATION 1 0.0001
721 GASTROINTESTINAL PAIN 1 0.0001
722 VIRAL INFECTION 3 0.0001
723 TOOTH DISORDER 2 0.0001
724 GAIT INABILITY 3 0.0001
725 COLITIS ULCERATIVE 4 0.0001
726 SNEEZING 2 0.0001
727 PANCREATITIS ACUTE 2 0.0001
728 BLOOD CALCIUM DECREASED 1 0.0001
729 TRANSIENT ISCHAEMIC ATTACK 3 0.0001
730 EYE INFECTION 1 0.0001
731 FLATULENCE 5 0.0001
732 DERMATITIS CONTACT 1 0.0001
733 GASTRIC HAEMORRHAGE 1 0.0001
734 ELECTROLYTE IMBALANCE 1 0.0001
735 EYELID OEDEMA 1 0.0001
736 BREAST CANCER 8 0.0001
737 CHILLS 10 0.0001
738 SURGERY 5 0.0001
739 LYMPHADENOPATHY 3 0.0001
740 DRUG INEFFECTIVE 111 0.0001
741 DISEASE RECURRENCE 4 0.0001
742 PRODUCT PRESCRIBING ERROR 2 0.0001
743 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 4 0.0001
744 BURSITIS 1 0.0001
745 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
746 GENERALISED OEDEMA 1 0.0001
747 DRY EYE 4 0.0001
748 INJECTION SITE DISCOLOURATION 1 0.0001
749 AGGRESSION 4 0.0001
750 DERMATITIS ALLERGIC 1 0.0001
751 WHITE BLOOD CELL COUNT INCREASED 3 0.0001
752 INTENTIONAL OVERDOSE 5 0.0001
753 HAEMOGLOBIN DECREASED 8 0.0001
754 INFUSION SITE PAIN 1 0.0001
755 ANAPHYLACTIC SHOCK 2 0.0001
756 SKIN ULCER 2 0.0001
757 DIPLOPIA 2 0.0001
758 MUSCULOSKELETAL PAIN 4 0.0001
759 URINARY TRACT INFECTION 13 0.0001
760 EAR INFECTION 2 0.0001
761 EYE HAEMORRHAGE 1 0.0001
762 JAUNDICE 2 0.0001
763 CONFUSIONAL STATE 12 0.0001
764 PULMONARY EMBOLISM 7 0.0001
765 TREATMENT NONCOMPLIANCE 4 0.0001
766 RESPIRATORY DISTRESS 2 0.0001
767 MEDICATION ERROR 4 0.0001
768 MASS 1 0.0001
769 DEVICE OCCLUSION 1 0.0001
770 MUSCLE SPASMS 13 0.0001
771 MUSCULAR WEAKNESS 8 0.0001
772 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 5 0.0001
773 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 5 0.0001
774 INTENTIONAL DOSE OMISSION 2 0.0001
775 BLOOD CREATINE PHOSPHOKINASE INCREASED 2 0.0001
776 GENERAL PHYSICAL HEALTH DETERIORATION 8 0.0001
777 HYPOKINESIA 1 0.0001
778 RASH 30 0.0001
779 INTENTIONAL PRODUCT MISUSE 6 0.0001
780 UNDERDOSE 5 0.0001
781 PALPITATIONS 8 0.0001
782 PSYCHOTIC DISORDER 2 0.0001
783 CARDIOMYOPATHY 1 0.0001
784 INSOMNIA 18 0.0001
785 URINARY INCONTINENCE 2 0.0001
786 OESOPHAGEAL CARCINOMA 2 0.0001
787 PULMONARY OEDEMA 3 0.0001
788 HAEMORRHAGE INTRACRANIAL 1 0.0001
789 BLOOD POTASSIUM DECREASED 2 0.0001
790 HYPOAESTHESIA ORAL 1 0.0001
791 URTICARIA 11 0.0001
792 DISCOMFORT 4 0.0001
793 DRUG DISPENSING ERROR 1 0.0001
794 HIP ARTHROPLASTY 1 0.0001
795 INJECTION SITE RASH 2 0.0001
796 PAIN 40 0.0001
797 LYMPHOMA 1 0.0001
798 ANKLE FRACTURE 1 0.0001
799 DELUSION 1 0.0001
800 ACUTE MYELOID LEUKAEMIA 1 0.0001
801 NERVOUS SYSTEM DISORDER 2 0.0001
802 PRODUCT USE ISSUE 12 0.0001
803 ARRHYTHMIA 3 0.0001
804 FALL 21 0.0001
805 MIGRAINE 6 0.0001
806 PRODUCTIVE COUGH 3 0.0001
807 OFF LABEL USE 55 0.0001
808 ABSCESS 1 0.0001
809 CARDIAC FAILURE CONGESTIVE 5 0.0001
810 HIP FRACTURE 2 0.0001
811 PROSTATE CANCER 5 0.0001
812 GASTROOESOPHAGEAL REFLUX DISEASE 5 0.0001
813 BLOOD CREATININE INCREASED 4 0.0001
814 MANIA 1 0.0001
815 STAPHYLOCOCCAL INFECTION 2 0.0001
816 TREATMENT FAILURE 5 0.0001
817 VISUAL ACUITY REDUCED 2 0.0001
818 GASTROINTESTINAL HAEMORRHAGE 5 0.0001
819 CELLULITIS 3 0.0001
820 MYALGIA 10 0.0001
821 CIRCULATORY COLLAPSE 1 0.0001
822 BALANCE DISORDER 5 0.0001
823 NIGHTMARE 2 0.0001
824 WEIGHT DECREASED 16 0.0001
825 COVID-19 10 0.0001
826 HEART RATE DECREASED 2 0.0001
827 PRODUCT USE IN UNAPPROVED INDICATION 14 0.0001
828 VISUAL IMPAIRMENT 7 0.0001
829 TACHYCARDIA 5 0.0001
830 GALLBLADDER DISORDER 1 0.0001
831 THERAPY INTERRUPTED 4 0.0001
832 MOBILITY DECREASED 4 0.0001
833 GASTROENTERITIS VIRAL 1 0.0001
834 OEDEMA 3 0.0001
835 PRODUCT DOSE OMISSION ISSUE 16 0.0001
836 HAEMATOCHEZIA 3 0.0001
837 CONJUNCTIVITIS 1 0.0001
838 DYSGEUSIA 4 0.0001
839 HYPOAESTHESIA 8 0.0001
840 DYSPNOEA EXERTIONAL 2 0.0001
841 ARTHRALGIA 22 0.0001
842 FEELING JITTERY 1 0.0001
843 DEATH 45 0.0001
844 DIZZINESS 26 0.0001
845 EYE IRRITATION 3 0.0001
846 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
847 HAEMORRHOIDS 1 0.0001
848 NASAL CONGESTION 3 0.0001
849 ARTHRITIS 4 0.0001
850 BLOOD PRESSURE ABNORMAL 1 0.0001
851 IRRITABILITY 3 0.0000
852 FULL BLOOD COUNT DECREASED 1 0.0000
853 DYSPNOEA 28 0.0000
854 NASOPHARYNGITIS 9 0.0000
855 ERYTHEMA 10 0.0000
856 OSTEOPOROSIS 2 0.0000
857 INJECTION SITE WARMTH 1 0.0000
858 ILLNESS 5 0.0000
859 CARDIAC ARREST 4 0.0000
860 INFECTION 7 0.0000
861 ROAD TRAFFIC ACCIDENT 2 0.0000
862 JOINT INJURY 1 0.0000
863 IRRITABLE BOWEL SYNDROME 1 0.0000
864 LIVER FUNCTION TEST INCREASED 1 0.0000
865 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
866 HEPATOTOXICITY 1 0.0000
867 THROMBOCYTOPENIA 5 0.0000
868 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
869 HEPATIC ENZYME INCREASED 3 0.0000
870 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
871 COMA 2 0.0000
872 RENAL CANCER 2 0.0000
873 RASH ERYTHEMATOUS 2 0.0000
874 HEPATIC CANCER 1 0.0000
875 DRUG INTOLERANCE 4 0.0000
876 LOCALISED INFECTION 1 0.0000
877 FIBROMYALGIA 1 0.0000
878 ATRIAL FIBRILLATION 4 0.0000
879 LIVER INJURY 1 0.0000
880 ALOPECIA 8 0.0000
881 EPISTAXIS 3 0.0000
882 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
883 FLUID RETENTION 2 0.0000
884 BLOOD PRESSURE INCREASED 6 0.0000
885 HOSPITALISATION 6 0.0000
886 PRURITUS 15 0.0000
887 SINUSITIS 4 0.0000
888 THERAPY CESSATION 2 0.0000
889 DRUG RESISTANCE 1 0.0000
890 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0000
891 EXPOSURE VIA SKIN CONTACT 1 0.0000
892 SPEECH DISORDER 2 0.0000
893 HYPERSENSITIVITY 7 0.0000
894 RENAL FAILURE 5 0.0000
895 INJECTION SITE BRUISING 3 0.0000
896 THROMBOSIS 3 0.0000
897 FATIGUE 29 0.0000
898 FEAR 1 0.0000
899 DRUG EFFECT DECREASED 2 0.0000
900 DRY MOUTH 3 0.0000
901 RASH PRURITIC 2 0.0000
902 INFLUENZA LIKE ILLNESS 3 0.0000
903 ABNORMAL DREAMS 1 0.0000
904 ANAPHYLACTIC REACTION 2 0.0000
905 TREMOR 6 0.0000
906 FEELING COLD 1 0.0000
907 NECK PAIN 2 0.0000
908 SKIN EXFOLIATION 3 0.0000
909 HYPERSOMNIA 1 0.0000
910 PRODUCT SUBSTITUTION ISSUE 2 0.0000
911 SEIZURE 4 0.0000
912 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 7 0.0000
913 MYOCARDIAL INFARCTION 6 0.0000
914 LIVER FUNCTION TEST ABNORMAL 1 0.0000
915 DYSPHONIA 2 0.0000
916 BLADDER CANCER 2 0.0000
917 LABORATORY TEST ABNORMAL 1 0.0000
918 HEADACHE 21 0.0000
919 GASTROINTESTINAL DISORDER 3 0.0000
920 ADVERSE DRUG REACTION 3 0.0000
921 FEELING ABNORMAL 8 0.0000
922 NO ADVERSE EVENT 6 0.0000
923 SUICIDE ATTEMPT 2 0.0000
924 PERIPHERAL SWELLING 5 0.0000
925 EMOTIONAL DISORDER 1 0.0000
926 OROPHARYNGEAL PAIN 3 0.0000
927 CHEST PAIN 6 0.0000
928 GYNAECOMASTIA 1 0.0000
929 SWELLING 3 0.0000
930 BLOOD GLUCOSE INCREASED 6 0.0000
931 HEAD INJURY 1 0.0000
932 GAIT DISTURBANCE 6 0.0000
933 LACTIC ACIDOSIS 1 0.0000
934 AMNESIA 2 0.0000
935 CHOLELITHIASIS 1 0.0000
936 DYSPEPSIA 3 0.0000
937 IMPAIRED HEALING 1 0.0000
938 DRY SKIN 4 0.0000
939 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
940 FLUSHING 3 0.0000
941 INJECTION SITE REACTION 2 0.0000
942 BURNING SENSATION 2 0.0000
943 SLEEP DISORDER 2 0.0000
944 ANXIETY 8 0.0000
945 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
946 OVERDOSE 6 0.0000
947 CRYING 1 0.0000
948 ACCIDENTAL OVERDOSE 1 0.0000
949 AGITATION 2 0.0000
950 ASTHMA 3 0.0000
951 DEPRESSION 6 0.0000
952 DIABETES MELLITUS 2 0.0000
953 INJECTION SITE SWELLING 2 0.0000
954 COUGH 7 0.0000
955 EXTRA DOSE ADMINISTERED 1 0.0000
956 DYSKINESIA 1 0.0000
957 PAIN IN EXTREMITY 7 0.0000
958 LOSS OF CONSCIOUSNESS 3 0.0000
959 DEVICE LEAKAGE 1 0.0000
960 MENTAL DISORDER 1 0.0000
961 MUSCULOSKELETAL STIFFNESS 2 0.0000
962 PRODUCT QUALITY ISSUE 3 0.0000
963 VISION BLURRED 3 0.0000
964 ADVERSE EVENT 2 0.0000
965 COGNITIVE DISORDER 1 0.0000
966 BLOOD GLUCOSE DECREASED 1 0.0000
967 CHEST DISCOMFORT 2 0.0000
968 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
969 INFLAMMATION 1 0.0000
970 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
971 HAEMORRHAGE 2 0.0000
972 DERMATITIS ATOPIC 1 0.0000
973 ARTHROPATHY 1 0.0000
974 INFLUENZA 2 0.0000
975 BLISTER 1 0.0000
976 CEREBROVASCULAR ACCIDENT 3 0.0000
977 INJECTION SITE ERYTHEMA 2 0.0000
978 ASTHENIA 6 0.0000
979 PSORIASIS 2 0.0000
980 HYPOTENSION 3 0.0000
981 INJECTION SITE PRURITUS 1 0.0000
982 DEVICE MALFUNCTION 1 0.0000
983 BRONCHITIS 1 0.0000
984 HOT FLUSH 1 0.0000
985 ACNE 1 0.0000
986 CHRONIC KIDNEY DISEASE 1 0.0000
987 INCORRECT DOSE ADMINISTERED 3 0.0000
988 PARAESTHESIA 2 0.0000
989 DEVICE ISSUE 1 0.0000
990 CARDIAC DISORDER 1 0.0000
991 CONTUSION 1 0.0000
992 INJECTION SITE PAIN 3 0.0000
993 WEIGHT INCREASED 2 0.0000
994 JOINT SWELLING 1 0.0000
995 MEMORY IMPAIRMENT 1 0.0000